Site is Being Upgraded

Flu vaccine comes to the rescue of blood sugar disease: Influenza A (H1N1) vaccine-based regenerative therapy for reversing diabetes:  Influenza A (H1N1) vaccine increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D, via down regulation of its target gene, 12/July/2018, 12.37 pm

Heat shock protein inhibitors as longevity-promoters: 17-DMAG, an HSP(heat shock protein)-90 inhibitor,  increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan, via down regulation of its target gene, 12/July/2018, 12.20 pm
July 12, 2018
A flavonoid way to lengthen lifespan: Quercetin, a flavonoid isolated from elder berries, onions and others,  may  increase insulin sensitivity, slow down cardiac aging, and increase life span, via up-regulation of BubR1 and others genes, 12/July/2018, 12.53 pm
July 12, 2018
Show all

Introduction: What they say

A study from the Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, 3715 McClintock Avenue, Los Angeles, California, USA; and Koch Institute at MIT, 500 Main Street, Cambridge, USA shows that “Fasting-Mimicking Diet Promotes Ngn3-Driven ß-Cell Regeneration to Reverse Diabetes.” This research paper was published, in the 23 February 2017 issue of the journal “Cell” [One of the best research journals in Biology with an I.F of 28 plus], by  Prof. and Director of Longevity institute Valter Longo, Cheng CW and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Flu vaccine comes to the rescue of blood sugar disease: Influenza A (H1N1) vaccine-based regenerative therapy for reversing diabetes:  Influenza A (H1N1) vaccine increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D, via down regulation of its target gene, 12/July/2018, 12.36 pm

 


From significance of the study to Public health relevance:

Given that: (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) Diabetes is going to be one of the top 10 causes of death by 2030; (3) the life-long painful injection/drug treatment is required to treat DM; (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult ß-cells that were lost in DM; (ii) a cheaper alternative to the existing expensive weight-loss drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, diabetes.


What is known?

It has recently been shown that fasting mimicking diet (FMD):(1) increases the expression of Sox17, Pdx-1 (Pancreatic And Duodenal Homeobox 1), & Ngn3 (Neurogenin-3) sequentially; (2) promotes regeneration of insulin-producing ß cells; (3) decreases PKA (Protein Kinase A) and mTOR activity; (4) increases reprogramming proteins Sox2 and Ngn3 expression; (5) increases insulin secretion; and (6) promotes glucose homeostasis, suggesting that FMD: (i) promotes reprogramming of pancreatic cells to restore insulin secretion in islets; and (ii) can reverse both T1D and T2D.


From research findings to Therapeutic opportunity:

This study suggests, first the first time, Influenza A (H1N1) vaccine-based regenerative therapy, with detailed mechanistic insights, for T1D and TIID.   Influenza A (H1N1)-vaccine  has been shown to protect against cardiovascular diseases, stroke, and others. However, the mechanism of action remains largely unknown.

Influenza A (H1N1) vaccine, by increasing the expression of its target genes, its may increase the expression of Sox17, Ngn3, Sox2, Pdx-1, NKX6.1, Pax6, INS, PD-L1, FGF19, and others (Fig. 1). Thereby,  it may: (1) decrease the expression of mTOR;  (2) increase generation of insulin-producing ß cells; (3) increase insulin secretion; and (4) promote glucose homeostasis, suggesting that Influenza A (H1N1) vaccine–may replace the need for FMD (Fast mimicking diet) or function as an effective alternative to FMD–may find its use in clinic in attenuating and/or in reversing both T1D and T2D, as they turn on most of the reprogramming/insulin-producing genes turned on by the FMD (Figs.1-2).

Figure 1. Mechanistic insights into how Influenza A (H1N1) vaccine, by turning on the expression of Ngn3, NKX6.1, Pax6, and INS and others anti-diabetic genes, may promote reprogramming of pancreatic cells to restore insulin secretion in islets; and reverse both T1D and T2D.

Figure 2. Influenza A (H1N1) vaccine as an anti-diabetic vaccine. Influenza A (H1N1) vaccine, by increasing the expression of Sox17, PDX1 and other anti-diabetic genes, may reverse both T1D and TIID.

 

 

 

 

 

 

 

 

 

 

Thus, Influenza A (H1N1) vaccine, either alone or in combination with other compounds, may be used to treat and cure T1D and T2D (Fig.2). Together, this study suggests, with detailed mechanistic insights, for the first time, that Influenza A (H1N1) vaccine-based therapy may be used to treat and/or cure both T1D and T2D.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How  Influenza A (H1N1) vaccine increases the expression of Sox17, Sox2, Pdx-1, and Ngn3?

Amount: $750#

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L., Flu vaccine comes to the rescue of blood sugar disease: Influenza A (H1N1) vaccine-based regenerative therapy for reversing diabetes:  Influenza A (H1N1) vaccine increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D, via down regulation of its target gene, 12/July/2018, 12.36 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite us, drop us a line at info@genomediscovery.org

Comments are closed.